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126Normal values and within-subject variability of
cardiac I-123 MIBG scintigraphy in healthy
individuals: Implications for clinical studies
G. Aernout Somsen, MD, PhD,a Hein J. Verberne, MD,b Eric Fleury,a and Alberto
Righetti, MDa
Background. Although several myocardial iodine 123 metaiodobenzylguanidine (MIBG)
indices are increasingly used to detect alterations in myocardial sympathetic activity in various
forms of cardiac pathology, published measurements of normal values and within-subject
variability are lacking.
Methods and Results. Twenty-five healthy volunteers underwent planar and single photon
emission computed tomography (SPECT) imaging. Heart-mediastinum ratio (H/M) and myo-
cardial washout were calculated from planar images comparing three different methods for the
assessment of myocardial activity: (1) global region over the myocardium (cavity included), (2)
global region over the myocardium (cavity excluded), and (3) fixed small myocardial region.
Segmental (relative) uptake and washout were assessed by SPECT. For all MIBG indices, the
interindividual variation was the lowest for methods 1 and 2. In SPECT this variation was low
for relative segmental uptake compared with washout. In 9 subjects a second MIBG scintigra-
phy was performed after 3 months. The within-subject variability of H/M and washout assessed
by planar methods 1 and 2 was 5%, whereas it was approximately 9% for planar method 3. For
relative segmental uptake from SPECT, this variability was 5%.
Conclusion. MIBG H/M (planar) and relative segmental uptake (SPECT) show a low
interindividual and within-subject variability. This enables the detection of small (regional)
variations in myocardial sympathetic nervous function, especially to monitor the effect of
therapeutic interventions in patients with various cardiac diseases. (J Nucl Cardiol 2004;11:
126-33.)
Key Words: Iodine 123 metaiodobenzylguanidine • scintigraphy • single photon emission
computed tomography • normal subjects
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MIBIn patients with various cardiac diseases increased
pathetic neuronal activity has been related to disease
rity and prognosis.1,2 Cardiac sympathetic neuronal
tion and activity can noninvasively be assessed by
of iodine 123–radiolabeled metaiodobenzylguani-
(MIBG), an analog of noradrenaline. As reduced
iac I-123 MIBG uptake has been related to progno-
this radiotracer can be used to evaluate the effect of
apeutic interventions on cardiac sympathetic activity.
iotensin-converting enzyme inhibitors,3,4 -receptor
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-3581/2004/$30.00  0inte0.1016/j.nuclcard.2002.10.010gonists,5-8 and spironolactone,9,10 which have been
wn to ameliorate functional capacity and prognosis in
ents with chronic heart failure, have been shown to
ease cardiac I-123 MIBG uptake and reduce its
hout in these patients, indicating favorable effects on
sympathetic nervous system. Therefore cardiac I-123
G imaging has become a widely used, valuable
invasive tool for the assessment of prognosis and
apeutic effects in various forms of cardiac pathology.
A drawback of the majority of the previous studies is
r nonrandomized and open-label design, because of
small number of patients studied and the necessity for
e clinical monitoring during dose titration of study
ication. As patients often serve as their own refer-
e in these studies, normal values and the physiolog-
variation of I-123 MIBG indices within the same
ent over time have to be assessed. In particular, this
in-subject variability needs to be evaluated to inter-
the significance of the detected alterations in I-123
G uptake and washout resulting from therapeuticrventions.
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Volume 11, Number 2;126-33 Cardiac I-123 MIBG scintigraphy in healthy individualsTo assess normal values and the within-subject
ability of commonly used I-123 MIBG indices, we
ormed cardiac I-123 MIBG scintigraphy in a rela-
ly large group of healthy subjects.
METHODS
dy Population
Healthy volunteers without a history of cardiac disease
with a less than 5% likelihood for coronary artery disease,
age and known risk factors taken into account, were
uded in the study. Subjects were not taking any medication.
ssess within-subject variability, patients were studied twice
time interval of 3 months. The characteristics of the
ects included in the study are shown in Table 1. The
ical Ethics Committee of our institution approved the
y. Written informed consent was obtained from all subjects
lled in the study.
uisition Protocol
Thyroid uptake was blocked by use of 200 mg potassium
de 1 hour before injection of 148 MBq I-123 MIBG
iochemical purity, 97%; specific activity, 148 MBq
3/mg MIBG) (Mallinckrodt Schweiz AG, Zu¨rich, Switzer-
). MIBG scintigraphy was performed with a dual-head
era (ADAC Epicardio, Milpitas, Calif) equipped with a
R collimator. At 15 minutes (early) and 240 minutes (late)
r injection of the radiopharmaceutical, planar images of the
ax were obtained during a 10-minute period in both the left
rior oblique (LAO) and anterior projections. Subsequently,
ographic images were obtained with the use of 32 frames
r 180° (90° per camera head) for 60 seconds per frame at
minutes (early) and 260 minutes (late) after tracer
ction. A 20% energy window was centered on the
-keV photopeak of I-123. Data collection was performed
a 128  128 matrix and a zoom factor of 1.46. The
ies were reconstructed with the PEGASYS software
le 1. Clinical characteristics of healthy volunteers (n
Single study (n  25)
Mean  SD Ra
(y) 30.5  8.5 2
/women 13/12
ght (kg) 63.4  9.6 4
gth (cm) 171.6  7.9 15
(mm Hg) 124  8.7 10
(mm Hg) 79  6.7 7
(beat/min) 65  11 4
Systolic blood pressure; DBP, diastolic blood pressure; HR, heartage (ADAC Laboratories, Milpitas, Calif) and fifth- imar Pega Butterworth prereconstruction filter. Images were
med to 250%. No correction for attenuation was applied
use, at the time of acquisition, no validated algorithm
available for I-123. Moreover, the majority of previous
ies did not use this correction, which allows for better
parison with data from this study. Slice thickness was 1
l (0.64 cm).
ge Analysis
Planar images. Cardiac MIBG uptake was determined
hree clinically used methods (Figure 1). For method 1, a
on of interest (ROI) was drawn over the myocardium
uding the left ventricular cavity.1,11,12 For method 2, an
was drawn over the myocardium excluding the left
ricular cavity. For method 3, peak count densities for the
cardium and upper mediastinum were determined.4,13
methods 1 and 2, ROIs were set over the upper
iastinum (in the anterior projection with a fixed area of
ixels) and manually drawn for the heart (anterior and
projection in both). The mean count density (for
hods 1 and 2) and the peak count densities (for method
ere calculated and corrected for injected dose and body
ght. I-123 MIBG uptake was expressed as the count
sity ratio between the heart and the upper mediastinum
). The myocardial I-123 MIBG (decay-corrected)
hout was calculated by use of the count densities (CD)
rding to the following algorithm:
ardiac I-123 MIBG washout (CDheart-early – CDheart-late/
CDheart-early) 100%
Single photon emission computed tomography im-
s. From tomographic images, cardiac short-axis slices
e reconstructed from basis to apex for bull’s-eye re-
struction. Three myocardial segments were manually
n (Figure 2), and segmental volumes were recon-
cted. Segmental count density and (decay-cor-
ed) washout were calculated and expressed as a percent-
of total myocardial count density in tomographic
)
Repeated study (n  9)
Mean  SD Range
29.6  10.5 24-56
4/5
61.9  9.9 49-80
170  6.7 159-178
123  10.9 110-140
79.4  5.3 70-90
70  12 61-90 25
nge
3-56
8-85
9-190
5-140
0-90
5-90ges.
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All values are expressed as mean SD. Correlations were
essed as Pearson correlation coefficients (r). The within-
ect variability was assessed by use of the coefficient of
ation (CV). The within-subject CV of repeated measure-
ts was calculated as follows (in which x and y represent two
rvations, at baseline and after 3 months)14:
s  ( x  y)2/ 2, m  ([ x  y]/ 2)2
CV Square root of (mean s/mean m)
s  standard deviation, m  mean
For each CV, the 95% confidence interval was calculated.
Figure 1. Schematic view of ROIs (shaded are
clinically used quantification methods: an ROI
ventricular cavity (method 1), an ROI drawn for
cavity (method 2), and peak count densities for the
3). H, Heart; C, cavity. For methods 1 and 2, an R
as a reference.
re 2. Segmental analysis of I-123 MIBG uptake on SPECT
ges with a polar map. AS, Anteroseptal; AL, anterolateral; I,
rior.variate analysis and forward stepwise regression analysis raphe performed for the identification of explanatory indepen-
variables of the various MIBG indices. Independent
ables tested were weight, age, length, heart rate, and both
olic and diastolic blood pressure at the time of acquisition.
value  .05 was considered to represent statistical
ificance. For all statistical analyses, StatView 4.57 (Abacus
cepts Inc, Berkeley, Calif) was used.
RESULTS
Twenty-five healthy volunteers were included in the
y and underwent cardiac I-123 MIBG scintigraphy.
e subjects were studied twice, with a time interval of
onths, to evaluate within-subject variability. All
ies could be reconstructed and analyzed.
mal Values of I-123 MIBG Indices
Planar images. For all planar methods used, the
rindividual variation, as expressed by the SD, was
tively high for cardiac uptake, whereas for mediasti-
uptake, H/M, and cardiac washout, this variation
eared to be lower (Tables 2, 3, and 4). For myocardial
ke, H/M, and washout, the interindividual variation
lower for method 1 compared with methods 2 and 3.
lowest H/M was found for method 1, whereas the
est H/M was found for method 3. However, when
three methods were compared, a higher H/M was
ciated with larger interindividual variation. Interin-
dual variation for H/M in the anterior projection was
htly less than in the LAO projection. There was a
d toward higher H/M in the anterior compared with
LAO projection without reaching the level of signif-
ce. No gender differences were found for any MIBG
x.
Single photon emission computed tomography
ges. For single photon emission computed tomog-
wn on planar images according to three
for the myocardium including the left
yocardium excluding the left ventricular
rdium and the upper mediastinum (method
40 pixels was placed in the mediastinumas) dra
drawn
the m
myoca
OI ofy (SPECT) acquisitions, a large interindividual vari-
atio
upta
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Volume 11, Number 2;126-33 Cardiac I-123 MIBG scintigraphy in healthy individualsn was found for total myocardial and segmental
ke (expressed as count density) and washout (Table
However, when segmental uptake in tomographic
ges was expressed as percent of maximum myocar-
uptake, this variation was reduced. In early and late
ges, percent I-123 MIBG uptake in the inferior
ent was significantly lower than in the lateral
ents (P .0001). No gender differences were found
any MIBG index.
Univariate analysis. Univariate analysis demon-
ted no significant correlation between any indepen-
t variable and any planar-derived MIBG indices.
ight and length were the only independent explana-
variables for the SPECT-derived myocardial MIBG
nt densities in early (r  0.49, P  .01, and r 
43, P  .03, respectively) and late (r  0.43, P 
le 2. Method 1: I-123 MIBG count densities (correct
hout for various projections in planar imaging (n 
PRO
Early
Mean CD
(MBq–1)
Me
(MBq
A 1.48  0.29 0.02
A 0.77  0.12 0.01
LAO 1.33  0.28 0.02
A 1.89  0.14
LAO 1.71  0.19
hout (%) A
hout (%) LAO
count density; H, Heart; M, mediastinum; PRO, projection used t
ay-corrected values.
le 3. Method 2: I-123 MIBG count densities (correct
hout for various projections in planar imaging (n 
PRO
Early
Mean CD
(MBq–1)
M
(MBq
A 1.55  0.31 0.02
A 0.77  0.12 0.01
LAO 1.40  0.27 0.02
A 2.02  0.20
LAO 1.83  0.19
hout (%) A
hout (%) LAO
count density; H, Heart; M, mediastinum; PRO, projection used t
ay-corrected values.and r  0.43, P  .04, respectively) images. wasdiac washout was not correlated with any indepen-
t variable. The weight-corrected count densities for
method are shown in Tables 2, 3, and 4.
Forward stepwise regression analysis. Only
ght entered the model as a significant determinant of
y cardiac I-123 MIBG uptake (but not late uptake or
hout).
hin-Subject Variability
The clinical characteristics of 9 individuals who
e studied twice did not differ from the overall normal
ulation (Table 1). During the follow-up of 3 months,
hanges in clinical characteristics were observed. All
ar and tomographic data are shown in Tables 6 and
espectively. On planar images, H/M and cardiac
r dose and body weight), H/M, and cardiac
Late
D
g–1)
Mean CD
(MBq–1)
Mean CD
(MBq–1 · kg–1)
.007 0.93  0.22 0.015  0.005
.003 0.47  0.10 0.007  0.002
.006 0.83  0.18 0.014  0.004
1.93  0.16
1.78  0.21
.0  5.5 (23.0  6.4)*
.4  5.2 (21.0  6.0)*
n myocardial ROI; A, anterior.
r dose and body weight), H/M, and cardiac
Late
D
kg–1)
Mean CD
(MBq–1)
Mean CD
(MBq–1 · kg–1)
.007 0.99  0.24 0.016  0.005
.003 0.47  0.10 0.007  0.002
.007 0.93  0.22 0.015  0.005
2.10  0.24
1.98  0.25
36.0  6.0 (23.7  6.9)*
33.0  9.0 (20.1  11.3)*
n myocardial ROI; A, anterior.ed fo
25)
an C
–1 · k
4  0
2  0
1  0
37
35
o obtaied fo
25)
ean C
–1 ·
5  0
2  0
3  0
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rior projection. Method 3 was inferior with respect to
in-subject variability compared with the other meth-
, as the CV was the highest for all indices. Between
hods 1 and 2, the within-subject variability did not
er for any indices in the anterior projection whereas
within-subject variability was slightly higher in the
projection with method 2. Figure 3 illustrates the
tionship between the initial measurements and the
ow-up measurements for the three different methods.
On tomographic images, a large within-subject vari-
ity was shown for segmental count densities and
hout (CV ranging from 0.11 to 0.14). However,
ental uptake expressed as a percentage of total
cardial uptake showed a very low within-subject
ability (Table 7).
DISCUSSION
In this study we showed the values of I-123 MIBG
le 4. Method 3: I-123 MIBG count densities (correct
hout for various projections in planar imaging (n 
PRO
Early
Mean CD
(MBq–1)
Me
(MBq
A 2.01  0.43 0.03
A 0.91  0.15 0.01
LAO 1.92  0.50 0.02
A 2.15  0.30
LAO 2.13  0.50
hout (%) A
hout (%) LAO
count density; H, Heart; M, mediastinum; PRO, projection used t
ay-corrected values.
le 5. Segmental I-123 MIBG uptake and washout in
Early
Mean CD
(MBq–1)
Mean CD
(MBq–1 ·
kg–1)
% of
maximum
uptake
Mean
(MBq
rt 1.01  0.32 0.016  0.007 — 0.74  0
tum 0.96  0.31 0.016  0.006 0.98  0.06 0.72  0
ral 1.11  0.34 0.018  0.007 1.07  0.05 0.79  0
rior 0.97  0.33 0.016  0.007 0.95  0.07* 0.70  0
.0001 compared with percent uptake in lateral segments.ces and the within-subject variability in the largest mayp of normal individuals ever reported in the litera-
. The I-123 MIBG parameters commonly used in
ical studies, such as H/M and cardiac washout,
ssed in planar images, showed a small interindi-
al variability compared with the dose-corrected
nt densities in the heart and mediastinum separately.
Although we anticipated an advantage to obtaining
myocardial count densities in the LAO projection
s overprojection of pulmonary tissue), a systemati-
y smaller myocardial ROI resulted in a higher inter-
vidual variability, as a result of unfavorable count
istics, for all three planar methods used. In addition,
significantly lower H/M and washout values were
d in the LAO projection compared with the anterior
ection. Therefore myocardial I-123 MIBG uptake is
erably assessed in the anterior projection to ensure
lowest variation and the highest resolution.
The planar quantification method 3 was character-
by the highest interindividual variability for all
ces as compared with the other planar methods. This
r dose and body weight), H/M, and cardiac
Late
D
g–1)
Mean CD
(MBq–1)
Mean CD
(MBq–1 · kg–1)
.010 1.30  0.30 0.021  0.007
.004 0.58  0.10 0.009  0.002
.007 1.33  0.33 0.015  0.005
2.16  0.17
2.30  0.25
.0  7.0 (22.3  8.12)*
.0  9.0 (16.5  10.5)*
n myocardial ROI; A, anterior.
graphic scintigraphy (n  25)
Late
Washout
(%)
Decay-
corrected
washout
(%)
Mean CD
(MBq–1 ·
kg–1)
% of
maximum
uptake
.012  0.005 — 27.0  7.4 11.4  8.9
.012  0.005 0.95  0.05* 24.4  8.0 8.2  9.7
.013  0.005 1.10  0.05 28.8  8.4 13.6  10.2
.011  0.005 0.95  0.07* 27.3  8.2 11.8  9.9ed fo
25)
an C
–1 · k
4  0
4  0
3  0
35
30
o obtaitomo
CD
–1)
.24 0
.23 0
.26 0
.23 0be due to the fact that peak count density in the
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Volume 11, Number 2;126-33 Cardiac I-123 MIBG scintigraphy in healthy individualscardium was predominantly found in the inferoapi-
region, which was highly affected by spillover from
acardiac structures, especially the liver. If heteroge-
us myocardial I-123 MIBG uptake, which has been
rted in various cardiac diseases, is also taken into
unt, method 3 can be considered to be less suitable
semiquantitative assessment of global cardiac I-123
G uptake.
For quantification method 2, the H/M ratios were
htly higher as compared with those obtained with
hod 1. However, a larger interindividual variability in
H/M ratios for method 2, which is probably caused
the difficulty in exactly defining the endocardial
er, may not result in a higher resolution. Therefore,
these data, it can be concluded that planar methods
nd 2 are equally reliable for the semiquantitative
lysis of cardiac I-123 MIBG uptake.
In this study the planar H/M values for quantifica-
method 1 in the anterior projection (early, 1.89 
, and late, 1.96  0.16) were lower than previously
le 6. Within-subject variability (3-month interval) of
thod (n  9)
Parameter PRO
Method 1
CV 95%
(early) A 0.05 0.03-0
(late) A 0.04 0.02-0
hout A 0.05 0.02-0
ay-corrected washout A 0.09 0.00-0
(early) LAO 0.06 0.04-0
(late) LAO 0.07 0.02-0
hout LAO 0.05 0.03-0
ay-corrected washout LAO 0.11 0.00-0
, Projection used to obtain myocardial ROI; 95% CI, 95% confiden
le 7. Within-subject variability (3-month interval)
elative (percent of maximal cardiac uptake)
mental I-123 MIBG uptake in tomographic
tigraphy (n  9)
BG indices
Early Late
CV 95% CI CV 95% CI
tum/heart (%) 0.03 0.02-0.04 0.02 0.01-0.03
ral/heart (%) 0.04 0.03-0.05 0.04 0.02-0.06
rior/heart (%) 0.04 0.02-0.06 0.05 0.03-0.08
CI, 95% Confidence interval of CV.rted H/M values in normal individuals. Morozumi et Dec5 using the same quantification method, demonstrated
y and late H/M values of 2.80  0.25 and 3.02 
, respectively. Differences in the size of the ROI
for the upper mediastinum corrected for differences
atrix size may explain this inconsistency. Morozumi
l used a fixed ROI of 144 pixels with a matrix size of
 256, as compared with 40 pixels with a matrix
of 128  128 in our study. The ROI used by
rozumi et al recalculated to a matrix size of 128 
decreases by a factor of 4 and is therefore smaller in
compared with our study (36 pixels vs 40 pixels,
ectively). The smaller ROI leads to a more precise
mation of nonspecific mediastinal uptake and is less
uenced by nonspecific lung uptake. This leads to a
er mediastinal count density and therefore explains
differences in H/M ratios. However, a smaller ROI
leads to a larger variability, as reflected by a larger
for late H/M. Our data are more in line with those of
let et al.16 Using method 1, they reported late H/M
es of 1.95  0.31 (range, 1.75-2.6).
The values for myocardial washout on planar images
e in keeping with previously reported values.15 On
ographic images, cardiac washout was significantly
er as compared with cardiac washout on planar
ges. Because pulmonary washout obtained from our
(49%  2.5%) is significantly higher than cardiac
hout, which is in keeping with data from other
ors,15 overprojection of pulmonary tissue on planar
ges may account for this difference. Although inter-
ject variability is high, washout measured on tomo-
hic images may better reflect sympathetic nervous
vity at a myocardial level. However, decay-corrected
hout showed a higher interindividual and within-
ject variability compared with non–decay-corrected
hout from both planar and SPECT acquisitions.
MIBG parameters in planar scintigraphy for each
Method 2 Method 3
CV 95% CI CV 95% CI
0.05 0.03-0.07 0.09 0.04-0.13
0.04 0.02-0.06 0.06 0.02-0.08
0.06 0.02-0.09 0.11 0.05-0.15
0.12 0.03-0.17 0.21 0.13-0.27
0.08 0.05-0.10 0.14 0.00-0.21
0.07 0.00-0.10 0.09 0.02-0.13
0.08 0.00-0.13 0.19 0.12-0.26
0.16 0.00-0.25 0.82 0.00-1.25
rval of CV; A, anterior.I-123
CI
.07
.05
.07
.15
.08
.10
.08
.17ay correction not only increases presumed activity
but
card
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ial washout showed lower values but higher varia-
. From a theoretical perspective, correction for phys-
decay in the calculation of biological washout is
erstandable. This correction, however, implies an
ease in variation. One could therefore wonder
ther small changes in sympathetic neuronal activity,
ssessed with myocardial I-123 MIBG washout, could
done better without decay correction (ie, smaller
ation).
As heterogeneous I-123 MIBG uptake on tomo-
hic images has been shown to be present in normal
viduals15,17 and patients with heart failure,12 we
ssed the segmental variability in uptake and washout.
ative I-123 MIBG uptake in the inferior wall was
er compared with the lateral segment, which is in
rdance with other studies.15,17 This regional differ-
e in I-123 MIBG uptake is probably due to both tissue
nuation and spatial variation in sympathetic nerve
vity, as the uptake of carbon 11–epinephrine, which
positron emission tomography equivalent of I-123
G, was also significantly reduced in the inferior wall
ealthy individuals.18 The interindividual variation of
ental count densities was large, probably because of
Figure 3. Within-subject variability for each plan
washout at baseline (observation 1) and after 3 mcount statistics (typically, 200 counts/pixel). How- uptar, when segmental uptake was expressed as a percent-
of total myocardial uptake, intersubject variability
low, which supports the use of relative measure-
ts to assess segmental variation in cardiac I-123
G uptake.
Several variables, such as age and body weight, have
n shown to be related to cardiac I-123 MIBG uptake
washout.19-22 In our study only weight was a
sistent independent determinant of various I-123
G SPECT indices in univariate analysis. However,
early cardiac uptake on SPECT images was related
weight in multivariate analysis. Therefore weight
ection of the I-123 MIBG SPECT data may be
sidered for clinical studies. Probably as a result of the
ller age range in our normal population compared
patient data from other studies, age was not an
pendent determinant of any of the I-123 MIBG
cardial indices.
The within-subject variability was lower for planar
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clusion
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